Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.431 SNIP: 0.716 CiteScore™: 2.6

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumes:
Volumen 22, 2020 Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v6.i2.20
10 pages

The Influence of Medicinal Mushroom Preparations on Mouse Tumors

Sinisa Ivankovic
Division of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia
Nevenka Hirsl
Division of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia
Ivan Jakopovich
Dr Myko San—Health from Mushrooms, Zagreb, Croatia
Mislav Jurin
Division of Molecular Medicine, Ruder Boskovic Institute, Zagreb, Croatia

SINOPSIS

Extracts from various medicinal mushrooms (Lentinus edodes, Grifola frondosa, and Coriolus (Trametes) versicolor), and particularly their proper blends, are of significant interest in selecting the best of them for treatment, or even prevention, of different pathological aberrations, including cancer. In this study, mushroom preparation effects on the proliferation of tumors and normal cells, respectively, as well as the survival rate of the mice with transplanted tumors, were determined. The incorporation of radioactive 3H thymidine in tumor cells (mouse squamous cell carcinoma [SCCVII], fibrosarcoma [FsaR], and melanoma [B16F10]) was inhibited in the presence of particular mushroom preparations. The effect was dose dependent and was different for tumor cell cultures used. On the other hand, the incorporation of radioactive 3H thymidine in normal Chinese hamster lung fibroblasts (V79 cell) increased, and the effect was generally dose dependent. The application of mushroom preparation to the mice bearing either SCCVII or FsaR tumor could influence their survival. On day 30 after SCCVII tumor cell transplantation, there was a 20% survival rate of mice in the control group, but 60—80% survived if particular mushroom extracts were applied. There were no survivors in the control group on the 36th day, but 40—60% were alive in the experimental groups. Furthermore, there was a 60% survival rate for mice with FsaR tumor when treated with mushroom preparations and a 20% survival rate in the control group on day 36 after tumor cell transplantation.Thus, the findings that the mushroom preparation tested induced a selective inhibition of tumor cell proliferation observed in vitro and a pronounced prolongation of the survival rate of tumor-bearing mice are of particular interest. These findings, together with the data that these compounds are not toxic to the organism, deserve further attention.


Articles with similar content:

Immunomodulation and Antitumor Activity of a Mushroom Product, Proflamin, Isolated from Flammulina velutipes (W. Curt.: Fr.) Singer (Agaricomycetideae)
International Journal of Medicinal Mushrooms, Vol.9, 2007, issue 2
Tetsuro Ikekawa, Hirofumi Maruyama
Peroral Effect on Tumor Progression of Soluble β-(1, 6)-Glucans Prepared by Acid Treatment from Agaricus blazei Murr. (Agaricaceae, Higher Basidiomycetes)
International Journal of Medicinal Mushrooms, Vol.2, 2000, issue 1
Hajimu Yamamoto, Masahide Noji, Yoshiaki Fujimiya, Ikukatsu Suzuki
Immunomodulating Activity of a b-Glucan Preparation, SCG, Extracted from a Culinary–Medicinal Mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae), and Application to Cancer Patients
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 4
Hitoji Yoshida, Yoshiyuki Adachi, Noriko N. Miura, Sachiko Nameda, Toshiro Yadomae, Mitsuhiro Nakajima, Naohito Ohno, Kenshi Yoshida, Toshie Harada
Dietary Turmeric Post-Treatment Decreases DMBA-Induced Hamster Buccal Pouch Tumor Growth by Altering Cell Proliferation and Apoptosis-Related Markers
Journal of Environmental Pathology, Toxicology and Oncology, Vol.31, 2012, issue 4
Pooja Tajpara, Gaurav Kumar, Girish Maru
Bioactive Components of Ganoderma lucidum (W.Curt.:Fr.) Lloyd Can Induce Apoptosis of Tumor Cells
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Martin Zimmerman-Kordmann, Jing-Song Zhang, Hua Fan, Werner Reutter, Qingjiu Tang